DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,203 filers reported holding DANAHER CORPORATION in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $49,539,509 | +53.9% | 198,277 | +53.9% | 0.18% | +57.1% |
| Q1 2024 | $32,180,667 | +10.9% | 128,867 | +2.8% | 0.11% | +3.7% |
| Q4 2023 | $29,008,648 | -9.8% | 125,394 | -3.3% | 0.11% | -18.8% |
| Q3 2023 | $32,173,856 | +5.6% | 129,681 | +2.1% | 0.13% | +13.7% |
| Q2 2023 | $30,468,480 | -5.5% | 126,952 | -0.7% | 0.12% | -8.6% |
| Q1 2023 | $32,232,387 | -4.7% | 127,886 | +0.3% | 0.13% | -9.9% |
| Q4 2022 | $33,838,176 | +8.0% | 127,491 | +5.1% | 0.14% | +3.6% |
| Q3 2022 | $31,326,000 | +9.3% | 121,283 | +7.2% | 0.14% | +18.1% |
| Q2 2022 | $28,671,000 | -22.9% | 113,094 | -10.8% | 0.12% | -11.5% |
| Q1 2022 | $37,191,000 | -5.0% | 126,792 | +6.6% | 0.13% | -8.4% |
| Q4 2021 | $39,139,000 | +11.8% | 118,961 | +3.4% | 0.14% | +1.4% |
| Q3 2021 | $35,012,000 | +10.5% | 115,006 | -2.6% | 0.14% | +10.2% |
| Q2 2021 | $31,685,000 | +22.9% | 118,072 | +3.1% | 0.13% | +16.4% |
| Q1 2021 | $25,782,000 | +4.6% | 114,546 | +3.2% | 0.11% | -5.2% |
| Q4 2020 | $24,645,000 | -1.3% | 110,944 | -4.3% | 0.12% | -8.7% |
| Q3 2020 | $24,958,000 | +20.9% | 115,904 | -0.7% | 0.13% | +5.0% |
| Q2 2020 | $20,643,000 | +75.3% | 116,739 | +37.2% | 0.12% | +45.8% |
| Q1 2020 | $11,775,000 | -11.2% | 85,072 | -1.5% | 0.08% | +10.7% |
| Q4 2019 | $13,253,000 | +7.0% | 86,349 | +0.7% | 0.08% | +2.7% |
| Q3 2019 | $12,381,000 | +3.6% | 85,722 | +2.5% | 0.07% | +2.8% |
| Q2 2019 | $11,950,000 | +14.7% | 83,615 | +5.9% | 0.07% | +9.2% |
| Q1 2019 | $10,420,000 | +57.1% | 78,929 | +22.7% | 0.06% | +32.7% |
| Q4 2018 | $6,634,000 | -11.1% | 64,328 | -6.3% | 0.05% | +6.5% |
| Q3 2018 | $7,464,000 | +10.9% | 68,687 | +0.7% | 0.05% | +9.5% |
| Q2 2018 | $6,730,000 | +13.4% | 68,204 | +12.5% | 0.04% | +7.7% |
| Q1 2018 | $5,937,000 | +3.6% | 60,639 | -1.8% | 0.04% | +11.4% |
| Q4 2017 | $5,732,000 | +7.6% | 61,753 | -0.6% | 0.04% | +6.1% |
| Q3 2017 | $5,329,000 | +4.2% | 62,122 | +2.5% | 0.03% | -5.7% |
| Q2 2017 | $5,113,000 | -1.0% | 60,592 | +0.3% | 0.04% | 0.0% |
| Q1 2017 | $5,164,000 | +10.1% | 60,381 | +0.2% | 0.04% | +2.9% |
| Q4 2016 | $4,689,000 | +6.0% | 60,233 | +6.7% | 0.03% | +3.0% |
| Q3 2016 | $4,425,000 | -27.9% | 56,448 | -7.1% | 0.03% | -28.3% |
| Q2 2016 | $6,136,000 | +11.6% | 60,752 | +4.8% | 0.05% | +12.2% |
| Q1 2016 | $5,499,000 | +3.1% | 57,972 | +0.9% | 0.04% | -6.8% |
| Q4 2015 | $5,334,000 | +3.4% | 57,434 | -5.1% | 0.04% | +7.3% |
| Q3 2015 | $5,157,000 | +0.9% | 60,521 | +1.3% | 0.04% | +13.9% |
| Q2 2015 | $5,113,000 | +7.7% | 59,742 | +6.8% | 0.04% | +5.9% |
| Q1 2015 | $4,749,000 | +6.6% | 55,940 | +7.6% | 0.03% | +13.3% |
| Q4 2014 | $4,456,000 | -11.1% | 51,991 | -21.2% | 0.03% | 0.0% |
| Q3 2014 | $5,015,000 | -3.4% | 66,003 | +0.0% | 0.03% | +3.4% |
| Q2 2014 | $5,194,000 | -0.7% | 65,977 | -5.4% | 0.03% | -6.5% |
| Q1 2014 | $5,230,000 | +2.8% | 69,736 | +5.8% | 0.03% | 0.0% |
| Q4 2013 | $5,087,000 | +8.3% | 65,900 | -2.8% | 0.03% | +3.3% |
| Q3 2013 | $4,698,000 | +11.2% | 67,772 | +1.5% | 0.03% | +3.4% |
| Q2 2013 | $4,225,000 | – | 66,750 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |